Investor Readiness Deck Review
Group 31 helps life-science companies transform complex data and ideas into clear, credible narratives that support investment and growth. The Investor Readiness Deck Review looks at how well your deck communicates the opportunity, evidence, differentiation, and potential value.
Science alone doesn’t move markets. Stories do.
Strong evidence matters. So does the way your team connects it to the unmet need, market opportunity, business case, and potential value. We identify where the investment story can be clearer and stronger. You receive prioritized recommendations your team can use for investor meetings, conferences, presentations, and strategic financing conversations.
“Group 31 has become an indispensable partner, enabling us to raise over $120M in funding and start 2 clinical trials.” –Jim B.
Let’s make your science impossible to ignore.
Get started.
What’s included
A focused, 2-hour expert review of one deck version (maximum 15 slides), with attention to investment narrative, structure, and formatting
A 30-minute follow-up meeting to discuss findings, answer questions, and align next steps
A concise, prioritized action list with quick wins and high-impact changes
Recommendations to improve readability and strengthen the signals the deck sends to investors
Price: $950 USD*
*Current clients: Contact Crystal for your discount code.
See Notes and terms for further details.
Who it’s for
Founders and leadership teams at biotech, pharmaceutical, medical device, diagnostics, and other life-science companies preparing to raise capital, meet with investors, or present at high-stakes events.
What we evaluate
- Strength and clarity of the investment narrative
- Connection between the scientific rationale and the business case
- Differentiation, competitive positioning, and market opportunity
- Business model, traction, and supporting evidence
- Flow, readability, financing story, and investor signals
How it works
- Purchase the Investor Readiness Review.
- You will receive an email with a secure link to upload your deck and schedule the meeting.
- G31 completes the review and meets with you to deliver recommendations and a simple action plan.
Notes and terms
- This review covers one deck version. For reviews of multiple versions or companion materials, contact us.
- All materials are treated as confidential.
- The review does not independently validate scientific, financial, clinical, legal, or market claims. It assesses how claims are communicated.
- Scheduling is subject to availability. You may reschedule by replying to the confirmation email.
- This offer is advisory. Implementation services are available on request.